Literature DB >> 2612122

Recurrent acute proptosis in atypical systemic lupus erythematosus.

R E Gray1, E A Jenkins, M A Hall, J J Kanski, B M Ansell.   

Abstract

A patient is described who developed acute proptosis, a rare complication of systemic lupus erythematosus, 16 years after the onset of the disease. Treatment with intravenous methylprednisolone produced rapid improvement, but swelling recurred a few days later. Intravenous corticosteroid was again effective and was continued orally without further episodes of proptosis. This patient is unusual in the long period of mild disease before the development of systemic complications, and in having antibodies to nuclear ribonucleoprotein but persistently normal titres of DNA-binding antibodies in her serum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612122     DOI: 10.1007/bf02032109

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Letter: Exophthalmos associated with systemic lupus erythematosus.

Authors:  L S Wildinson; R S Panush
Journal:  Arthritis Rheum       Date:  1975 Mar-Apr

2.  The ocular manifestations of the diffuse collagen diseases.

Authors:  R W HOLLENHORST; J W HENDERSON
Journal:  Am J Med Sci       Date:  1951-02       Impact factor: 2.378

3.  Proptosis secondary to systemic lupus erythematosus.

Authors:  E H Brenner; J P Shock
Journal:  Arch Ophthalmol       Date:  1974-01

Review 4.  Pathology of 'pseudotumours' of the orbit: a review.

Authors:  A Garner
Journal:  J Clin Pathol       Date:  1973-09       Impact factor: 3.411

5.  Megadose corticosteroid therapy in systemic lupus erythematosus.

Authors:  W J Fessel
Journal:  J Rheumatol       Date:  1980 Jul-Aug       Impact factor: 4.666

6.  Graves' disease presenting with bilateral acute painful proptosis, ptosis, ophthalmoplegia, and visual loss.

Authors:  T J Leonard; E M Graham; M R Stanford; M D Sanders
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

7.  Ocular involvement in lupus erythematosus profundus (panniculitis).

Authors:  T Nowinski; V Bernardino; M Naidoff; R Parrish
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

8.  Orbital inflammation, myositis, and systemic lupus erythematosus.

Authors:  B S Grimson; K B Simons
Journal:  Arch Ophthalmol       Date:  1983-05

Review 9.  Pulse methylprednisolone in SLE.

Authors:  R P Kimberly
Journal:  Clin Rheum Dis       Date:  1982-04

10.  Exophthalmos in systemic lupus erythematosus.

Authors:  A D Bankhurst; T J Carlow; R W Reidy
Journal:  Ann Ophthalmol       Date:  1984-07
View more
  3 in total

1.  Acute ocular ischaemia and orbital inflammation associated with systemic lupus erythematosus.

Authors:  P Stavrou; P I Murray; K Batta; C Gordon
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

Review 2.  Non-infectious orbital vasculitides.

Authors:  B Perumal; E H Black; F Levin; J J Servat
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

Review 3.  Orbital myositis in systemic lupus erythematosus: a case-based review.

Authors:  Voulgari V Paraskevi; Venetsanopoulou I Aliki; Pieta Antigone; Tziortzioti Zoi; Zikou K Anastasia; Drosos A Alexandros
Journal:  Rheumatol Int       Date:  2022-04-19       Impact factor: 3.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.